Results 201 to 210 of about 22,234 (251)

Development of a selection marker-free rice-based oral cholera toxin B-subunit vaccine and determination of genomic location and structure of the transgenes by using a whole genome resequencing approach

, 2015
Mio Mejima, 未央 目島
openalex   +1 more source

A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique

, 2017
Rachel Démolis, Carlos Botão, Leonardo W Heyerdahl, Bradford D. Gessner, Philippe Cavailler, Celestino Sinai, Amílcar Magaço, Jean-Bernard Le Gargasson, Martin Mengel, Élise Guillermet   +9 more
openalex   +1 more source

Vaccines for preventing cholera [PDF]

, 2013
Cabana Puig, Xavier, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Statement on oral cholera vaccination.

Canada communicable disease report = Releve des maladies transmissibles au Canada, 1999
openaire   +1 more source

Live Oral Cholera Vaccine [PDF]

Clinical Immunotherapeutics, 1995
Rick Davis, Caroline M. Spencer
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Embracing Oral Cholera Vaccine — The Shifting Response to Cholera

New England Journal of Medicine, 2014
Despite evidence of the safety and efficacy of oral cholera vaccines, they were not included in the prevention package during the 2010 Haitian cholera epidemic. But some major obstacles to the use of OCVs in cholera outbreaks have since been overcome.
Jean William, Pape, Vanessa, Rouzier
openaire   +2 more sources

Vaxchora: A Single-Dose Oral Cholera Vaccine

Annals of Pharmacotherapy, 2017
Objective: To review trials evaluating the efficacy and safety of Vaxchora, a reformulated, single-dose, oral, lyophilized Vibrio cholerae CVD 103-HgR vaccine for the prevention of travel-related cholera caused by V cholerae serogroup O1. Data Sources: A literature search was conducted using MEDLINE (1946 to January week 3, 2017) and EMBASE (1996 to ...
Adriana, Cabrera, Jayne E, Lepage, Karyn M, Sullivan, Sheila M, Seed   +3 more
openaire   +2 more sources

Oral cholera vaccines: use in clinical practice

The Lancet Infectious Diseases, 2006
Cholera continues to occur globally, particularly in sub-Saharan Africa and Asia. Oral cholera vaccines have been developed and have now been used for several years, primarily in traveller populations. The licensure in the European Union of a killed whole cell cholera vaccine combined with the recombinant B subunit of cholera toxin (rCTB-WC) has ...
David R, Hill, Lisa, Ford, David G, Lalloo   +2 more
openaire   +2 more sources

A Prototype Live Oral Cholera Vaccine

Nature, 1971
Using the methods of molecular genetics it should be possible to develop a cholera vaccine that produces long lasting immunity. To this end Vibrio cholerae mutants deficient in choleragenic activity have been isolated.
openaire   +2 more sources

Live oral vaccines against cholera: An update

Vaccine, 1993
One hundred years elapsed between the first (live, parenteral) cholera vaccine that entered clinical trials in 1885 and the field trials of two oral inactivated cholera vaccines undertaken in Bangladesh in the mid-1980s. The oral inactivated vaccines advanced the art by establishing, convincingly, that oral vaccines could protect (although multiple ...
M M, Levine, J B, Kaper
openaire   +2 more sources